CMP - Cipla Medpro South Africa - Results of RT12-2011 tender and IMS update

CMP - Cipla Medpro South Africa - Results of RT12-2011 tender and IMS update    
CIPLA MEDPRO SOUTH AFRICA LIMITED                                               
(Incorporated in the Republic of South Africa)                                  
(Registration number 2002/018027/06)                                            
(ISIN Number: ZAE000128179   Share Code: CMP)                                   
("Cipla Medpro" or "the Company")                                               
RESULTS OF RT12-2011 TENDER AND IMS UPDATE                                      
The Chief Executive Officer of Cipla Medpro, Mr Jerome Smith, is pleased to     
announce the following developments at Cipla Medpro.                            
IMS                                                                             
Based on IMS data, Cipla Medpro has achieved the third position, by value, for  
the months of March and April 2011, thereby continuing on its goal to achieve   
the overall third position by the end of 2011.                                  
RT12-2011 TENDER - CIPLA AGRIMED                                                
Cipla Agrimed (Pty) Ltd ("Cipla Agrimed"), our animal health company which      
focuses on livestock production, was successful in winning a significant        
portion of the national tender RT12-2011 ("the Tender") in May this year. The   
Tender includes the supply of several animal health products to all nine        
provinces in South Africa. It is anticipated to run over a two year period and  
in total 12 items consisting of seven different products were allocated to      
Cipla Agrimed. Some of the products are amongst the highest volume products in  
the animal health Tender, which are used for the control of ectoparasites       
(control of ticks and sheep scab) in several of the provinces.                  
Mr Smith was quoted as saying: "The estimated annual sales resulting from this  
Tender could be as much as R50 million per annum, and it is the first time      
that a new entrant has been able to secure a major share of this Tender which   
has been dominated by other players for the past decade."                       
In addition, the Tender will also give Cipla Agrimed exposure to a much         
broader sector of the rural market in areas where traditionally the South       
African Government is still very involved and responsible for the control of    
diseases. These communities are switching over from small developing farmers    
to larger commercial farming enterprises, which should grow substantially in    
the future, giving Cipla Agrimed greater potential for growth of commercial     
sales in these areas.                                                           
Cape Town                                                                       
1 June 2011                                                                     
Sponsor                                                                         
Nedbank Capital                                                                 
Date: 01/06/2011 14:00:01 Supplied by www.sharenet.co.za                     
Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.